Skip to content

Nasdaq · CIK 0001723069

TLSA Tiziana Life Sciences Ltd

Insider trading from SEC Form 4. Last filing 14 d ago. Close $1.09 on Oct 12, 2026, +42% from the 52-week low and -49% from the high.

In brief

Tiziana Life Sciences Ltd (TLSA) has 7 SEC Form 4 filings on file from 2 insiders, the latest filed on Sep 29, 2026. In the last 90 days insiders made 4 open-market buys worth $1.0M and 0 open-market sells worth $0, net +$1.0M.

4 open-market trades have been scored at TLSA. The newest: Gabriele M Cerrone (director and 10% owner) bought $17k of stock on Jun 12, 2026, filed Aug 7, 2026, scored 10 (weak). The largest of the 4 shown: Ivor Elrifi (Chief Executive Officer) bought $667k on Aug 3, 2026, scored 56 (moderate). 2 insiders bought within 14 days of each other around Jul 21, 2026.

Last 90 days

Net insider value
+$1.0M
more bought than sold
Buys
4
$1.0M by 2 insiders
Sells
0
$0 by 0 insiders
Insiders on file
2
with a Form 4 at this company

Price and insider trades, last year

TLSAOct 12, 2026 · close 1.09

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™

Signals

Open-market buys and sells at Tiziana Life Sciences Ltd, scored.

ScoreInsiderValueHoldingsPrice contextFiled
10WeakGabriele M Cerrone
director, owner
buy
$17k
15,000 shares
+0%-
39WeakGabriele M Cerrone
director, owner
buy
$42k
42,357 shares
+0%-
55ModerateIvor Elrifi
Chief Executive Officer
buy
$319k
321,423 shares
+7%-
56ModerateIvor Elrifi
Chief Executive Officer
buy
$667k
667,000 shares
+18%-

Transactions

Every row filed, 9 in all.

DateInsiderTransactionSharesPriceValueHoldings afterFiled
Aug 15, 2026Ivor Elrifi
Chief Executive Officer
MOption exercise
COMMON STOCKindirect: By trust
+1,050,000--5,843,68414 d ago
Aug 15, 2026Ivor Elrifi
Chief Executive Officer
MOption exercise
Restricted Stock Unitderivative
-1,050,000--2,100,00014 d ago
Jul 21, 2026Gabriele M Cerrone
director, owner
POpen-market purchase
COMMON STOCKindirect: Via Panetta Partners Limited
+42,357$0.99$42k44,814,587Aug 7, 2026
Jun 12, 2026Gabriele M Cerrone
director, owner
POpen-market purchase
COMMON STOCKindirect: Via Panetta Partners Limited
+15,000$1.11$17k44,772,230Aug 7, 2026
Aug 4, 2026Ivor Elrifi
Chief Executive Officer
POpen-market purchase
COMMON STOCKindirect: By trust
+83,807$0.97$81k4,556,068Aug 6, 2026
Aug 5, 2026Ivor Elrifi
Chief Executive Officer
POpen-market purchase
COMMON STOCKindirect: By trust
+237,616$1.00$238k4,793,684Aug 6, 2026
Aug 3, 2026Ivor Elrifi
Chief Executive Officer
POpen-market purchase
COMMON STOCKindirect: By trust
+667,000$1.00$667k4,472,261Aug 5, 2026
Jul 21, 2026Gabriele M Cerrone
director, owner
AGrant or award
COMMON STOCKindirect: Via Panetta Partners Limited
+42,357$0.99$42k44,814,587Jul 23, 2026
Jun 12, 2026Gabriele M Cerrone
director, owner
AGrant or award
COMMON STOCKindirect: Via Panetta Partners Limited
+15,000$1.11$17k44,772,230Jun 17, 2026

Insiders

Everyone who has filed a Form 4 here.

Questions about TLSA

Answered from the filings on this page, as of the latest one.

Are insiders buying TLSA?

As of Sep 29, 2026, SEC Form 4 filings show 4 open-market buys worth $1.0M by 2 insiders and 0 open-market sells worth $0 by 0 insiders at Tiziana Life Sciences Ltd in the last 90 days, net +$1.0M. Only purchases (code P) and sales (code S) count; grants, option exercises and tax withholding do not.

Who was the last insider to trade TLSA on the open market?

Gabriele M Cerrone (director and 10% owner) bought $17k of TLSA on Jun 12, 2026 and filed the Form 4 on Aug 7, 2026. InsiderTell scored 10 (weak).

How many insiders file Form 4 at Tiziana Life Sciences Ltd?

2 people have filed a Form 4 at Tiziana Life Sciences Ltd, among them Gabriele M Cerrone (director, 10% owner and chair), Ivor Elrifi (Chief Executive Officer). Officers, directors and holders of more than 10% of a share class must report their trades within two business days.

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

TLSA insider trading: Tiziana Life Sciences Ltd | InsiderTell